Ghost Tree Capital’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Ghost Tree Capital’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-473,562	Closed	-$1.8M	–	49
2022 Q1	$1.8M	Sell	473,562 -430,663	-48%	-$1.94M	0.39%	35
2021 Q4	$4.07M	Hold	904,225	–	–	1.46%	28
2021 Q3	$4.21M	Hold	904,225	–	–	1.23%	31
2021 Q2	$6.38M	Hold	904,225	–	–	1.75%	20
2021 Q1	$5.14M	Buy	904,225 +704,225	+352%	+$4.27M	1.21%	26
2020 Q4	$922K	Hold	200,000	–	–	0.21%	42
2020 Q3	$778K	Sell	200,000 -140,000	-41%	-$2.81M	0.22%	41
2020 Q2	$9.78M	Buy	340,000 +225,000	+196%	+$5.21M	2.58%	15
2020 Q1	$2.48M	Buy	+115,000	New	+$2.61M	0.66%	32

Other funds holding STSA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ghost Tree Capital's STSA Position: Q2 2022 in Review

Ghost Tree Capital sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q2 2022, closing a stake of 473,562 shares — an estimated $1.8M sold.

Ghost Tree Capital first reported a position in STSA in Q1 2020 and held it in 9 quarters. The position peaked at $9.78M in Q2 2020. 32 funds tracked by Wall St. Rank hold STSA as of Q2 2022.

Ghost Tree Capital reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Ghost Tree Capital sold 473,562 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $1.8M.
Ghost Tree Capital first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 9 quarters.
Ghost Tree Capital's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $9.78M in Q2 2020.
32 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Ghost Tree Capital's 13F filing for Q2 2022, filed 15 Aug 2022.